Lexicon Pharmaceuticals, Inc. Revenue 2009–2025
Lexicon Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lexicon Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 21.1 M, a 1572.11% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 65.4 M, a 1322.31% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2025 was 49.8 M, a 729.91% increase from 2024.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2024 was 6.0 M, a 440.63% increase from 2023.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2023 was 1.1 M.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Lexicon Pharmaceuticals, Inc. (LXRX) — Frequently Asked Questions
Lexicon Pharmaceuticals, Inc. (LXRX) is a publicly traded US company. It has a market capitalization of $684M. In fiscal 2025 it reported revenue of $50M and net income of -$50M. Explore LXRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Lexicon Pharmaceuticals, Inc.'s market cap?
Lexicon Pharmaceuticals, Inc. (LXRX) has a market capitalization of $684M.
What is the LXRX stock price?
LXRX trades at $1.89 (+0.27% on the day).
How much revenue does Lexicon Pharmaceuticals, Inc. make?
Lexicon Pharmaceuticals, Inc. reported revenue of $50M in fiscal 2025.
Is LXRX profitable?
In fiscal 2025, Lexicon Pharmaceuticals, Inc. reported net income of -$50M.